Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice

T M Peneder1, P Scholze, M L Berger

  • 1Center for Brain Research, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria.

Neuroscience
|February 22, 2011
PubMed

Insights

Manganese exposure and alpha-synuclein mutations did not cause Parkinson's disease-like neurodegeneration in mice. However, manganese interacted with wild-type alpha-synuclein, affecting dopamine neurotransmission.

Area of Science:

  • Neuroscience
  • Toxicology
  • Genetics

Background:

  • Parkinson's disease (PD) involves genetic and environmental factors.
  • Alpha-synuclein (α-syn) mutations cause familial PD.
  • Manganese (Mn) exposure can induce parkinsonism.

Purpose of the Study:

  • To investigate the combined effects of genetic α-syn variations and chronic Mn exposure on PD-like pathology.
  • To determine if Mn and α-syn interact to cause neurodegeneration in a mouse model.

Main Methods:

  • Transgenic mice expressing human wild-type or mutated α-syn were exposed to Mn or control diets.
  • Locomotor activity, striatal Mn levels, neuron counts, and neurotransmitter metabolites (HVA/DA) were analyzed.
  • Analyses included three-way and two-way ANOVAs across different ages (7 and 20 months).

Main Results:

  • Mn exposure increased locomotor activity but did not cause significant neurodegeneration in substantia nigra neurons.
  • Striatal Mn levels increased significantly with Mn exposure.
  • In 7-month-old mice, Mn exposure reduced striatal HVA/DA ratios and aspartate levels specifically in mice with wild-type human α-syn.

Conclusions:

  • Under these conditions, Mn and α-syn (wild-type or mutated) did not induce PD-like neurodegenerative changes.
  • Mn selectively interacted with wild-type human α-syn, impacting dopamine neurotransmission indices.
  • A correlation was observed between striatal dopamine metabolism and aspartate release.